Healthcare
Germany’s Roads in Crisis: A Billion Phone Violations a Year as E-Scooter Helmet Law Kicks In
German traffic authorities are grappling with a staggering reality: an estimated one billion mobile phone infractions occur annually on the...
Germany’s Divided Disability Safety Net: Private Insurers Pay 80% of Claims While State Rejects Nearly Half
The gap between Germany's two disability benefit systems has never been wider. A roofer who can no longer climb scaffolding...
Germany Adds Pesticide-Triggered Parkinson’s to Occupational Disease List, as Only 30% of Claims Win Approval
The path to compensation for occupational illnesses in Germany remains a steep climb. Of the 90,749 suspected cases reported last...
From Heated Gaming Chairs to E-Ink Viewers: The Workplace Ergonomics Boom of 2026
Neck, shoulder and back pain among desk workers has become a major concern, and the latest product launches from early...
For German Companies, Healthy Staff Are a Sound Investment: €2.70 Back for Every Euro Spent
In Bremen, ten former tram drivers now handle passport applications. They were reassigned by the Bremer Straßenbahn AG after failing...
BioNTech’s Bet on BNT323 Intensifies as Restructuring and Pipeline Data Pave Way for Regulatory Milestone
The next few months will decide whether BioNTech can turn its sprawling oncology pipeline into a revenue-generating reality. With a...
Eli Lilly’s Most Consequential Weekend: New Mounjaro Data Meets a $3.8 Billion Vaccine Pivot
Eli Lilly closed last week with a flurry of news that turned the stock into a tale of two catalysts....
Eli Lilly’s Two-Front Victory: A Trillion-Dollar Valuation and a Pharmacy Benefit Win Reshape the Obesity Landscape
Eli Lilly has barrelled past a historic threshold, becoming the first pharmaceutical company to reach a market capitalisation of $1...
Siemens Healthineers Shares Test Support After China Diagnostics Hit Sinks Earnings and Guidance
The structural breakdown in China’s diagnostics market has sent Siemens Healthineers shares spiralling to their weakest level in a year,...
BioNTech’s $650 Million R&D Quarter: Shareholders Back Board Expansion as Market Awaits Lung Cancer Data
Despite sitting on nearly $20 billion in cash, BioNTech is burning through money at an accelerating pace as it races...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
